养血清脑颗粒联合甲磺酸倍他司汀治疗脑梗死伴头晕疾病的临床效果  

Clinical Effect of Yangxueqingnao Granules Combined with Betahistine Mesylate in Treatment of Cerebral Infarction with Dizziness

作　　者：李章羽 陈东丽[2] 宋丽云[2] LI Zhangyu;CHEN Dongli;SONG Liyun(Department of Internal Medicine,Beijing Shunyi District Airport Hospital,Beijing 101318,China;Department of Neurology,Beijing Shunyi District Airport Hospital,Beijing 101318,China)

机构地区：[1]北京市顺义区空港医院内科,北京101318 [2]北京市顺义区空港医院神经内科,北京101318

出　　处：《系统医学》2025年第2期103-106,共4页Systems Medicine

摘　　要：目的分析养血清脑颗粒联合甲磺酸倍他司汀治疗脑梗死伴头晕疾病的临床效果。方法非随机选取2022年8月—2023年10月北京市顺义区空港医院收治的82例脑梗死伴头晕患者为研究对象。根据治疗方案不同分为两组,各41例。常规组采用甲磺酸倍他司汀单一疗法,研究组在常规组基础上加用养血清脑颗粒。比较两组临床疗效、脑血流动力学参数、头晕程度、生活质量。结果研究组治疗总有效率为97.56%(40/41),高于常规组的80.49%(33/41),差异有统计学意义(χ^(2)=4.493,P<0.05)。治疗后研究组脑血流动力学参数均优于常规组,差异有统计学意义(P均<0.05)。研究组头晕严重程度轻于常规组,差异有统计学意义(P<0.05)。治疗后研究组生活质量高于常规组,差异有统计学意义(P均<0.05)。结论脑梗死伴头晕患者通过药物联合法治疗,疗效较好,可改善头晕症状和生活质量。Objective To analyze the clinical effect of Yangxueqingnao granules combined with betahistine mesylate in treating cerebral infarction with dizziness.Methods From August 2022 to October 2023,eighty-two patients with cerebral infarction and dizziness admitted to Beijing Shunyi District Airport Hospital were non-randomly selected as the research objects.They were divided into two groups according to different treatment plans,forty-one cases in each group.The conventional group was treated with betahistine mesylate monotherapy,and the study group was supplemented with Yangxueqingnao.The clinical efficiency,cerebral hemodynamic parameters,degree of dizziness and quality of life were compared between the two groups.Results The total effective rate of the study group was 97.56%(40/41),which was higher than 80.49%(33/41)of the conventional group,the difference was statistically significant(χ^(2)=4.493,P<0.05).After treatment,the cerebral hemodynamic parameters of the study group were better than those of the conventional group,and the differences were statistically significant(all P<0.05).The severity of dizziness in the study group was lighter than that in the conventional group,and the difference was statistically significant(P<0.05).After treatment,the quality of life of the study group were higher than those of the conventional group,and the differences were statistically significant(all P<0.05).Conclusion Patients with cerebral infarction accompanied by dizziness can be treated by drug combination,dizziness symptoms can be improved,the curative effect is better,and the quality of life can be improved.

关 键 词：养血清脑颗粒 甲磺酸倍他司汀 联合疗法 脑梗死 头晕 疗效 

分 类 号：R4[医药卫生—临床医学]